AUPH Earnings
Latest Revenue83.2M
Latest Net Income37.4M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.29 | 83.2M | 37.4M | +18.9% | +81.2% |
| Q1 2026 | $0.26 | 77.7M | 34.4M | +24.4% | +52.9% |
| Q4 2025 | $1.60 | 77.1M | 210.8M | +28.8% | +15,900.0% |
| Q3 2025 | $0.24 | 73.5M | 31.6M | +8.4% | +140.0% |
| Q2 2025 | $0.16 | 70.0M | 21.5M | +22.4% | +1,500.0% |
| Q1 2025 | $0.17 | 62.5M | 23.3M | +24.2% | +342.9% |
| Q4 2024 | $0.01 | 59.9M | 1.4M | +32.8% | +105.3% |
| Q3 2024 | $0.10 | 67.8M | 14.3M | +24.3% | +211.1% |
| Q2 2024 | $0.01 | 57.2M | 722.0K | — | — |
| Q1 2024 | -$0.07 | 50.3M | -10749000 | — | — |
| Q4 2023 | -$0.19 | 45.1M | -26875000 | — | — |
| Q3 2023 | -$0.09 | 54.5M | -13447000 | — | — |
Aurinia Pharmaceuticals (AUPH) — Earnings